FPL 52757

FPL 52758 is Na salt of FPL 52757; structure in first source; RN given refers to parent cpd

Also Known As:

6,8-diethyl-5-hydroxychromone-2-carboxylic acid; FPL 52757, monosodium salt; FPL 52758; FPL-52757

Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

1.	Drug-Related Side Effects and Adverse Reactions 06/01/1990 - "The failure of animal toxicity studies to predict drug toxicity in humans, due to species differences in metabolism and pharmacokinetics, is illustrated by reference to the anti-inflammatory antiviral terpenoid carbenoxolone, the antiasthmatic candidate drug FPL 52757, and the cardiotonic drug amrinone. "
2.	Pain (Aches) 01/01/1980 - "The itch and slight pain caused by antigen injection was not experienced in the FPL 52758 pretreated areas. "
3.	Atopic Dermatitis (Atopic Eczema) 01/01/1980 - "injection of 10 microgram FPL 52758 significantly reduced the weal and flare reaction induced by specific antigen in 11 patients with atopic dermatitis. "

1.	Anti-Asthmatic Agents (Antiasthmatic Drugs)
2.	Terpenes (Terpenoids)
3.	Cardiotonic Agents (Cardiac Stimulants)
4.	Carbenoxolone
5.	Antiviral Agents (Antivirals)
6.	Amrinone (Amrinon)
7.	Antigens